Sign Up Today and Learn More About Star Therapeutics Stock
Invest in or calculate the value of your shares in Star Therapeutics or other pre-IPO companies through EquityZen's platform.
Star Therapeutics Stock (STTH)
Star Therapeutics mission is to develop therapies for as many diseases as possible for millions of patients.
About Star Therapeutics Stock
Founded
2018
Headquarters
South San Francisco, CA, US
Industries
Messaging and Telecommunications, Content and Publishing, Sports
Star Therapeutics Press Mentions
Stay in the know about the latest news on Star Therapeutics
Star Therapeutics Receives FDA Fast Track Designation for VGA039 in Von Willebrand Disease (VWD)
biospace • Jan 08, 2025
Star Therapeutics Receives FDA Fast Track Designation for VGA039 in Von Willebrand Disease (VWD)
businesswire • Jan 06, 2025
Star Therapeutics to Present at 43rd Annual J.P. Morgan Healthcare Conference
biospace • Jan 02, 2025
Star Therapeutics to Present at 43rd Annual J.P. Morgan Healthcare Conference
businesswire • Jan 02, 2025
Star Therapeutics Presents Interim Clinical Data for VGA039 in Patients with Von Willebrand Disease (VWD) at ASH 2024
biospace • Dec 09, 2024
Star Therapeutics Management
Leadership team at Star Therapeutics
Board Observer
Amrit Nagpal
Board Member
Carl L. Gordon
Join now and verify your accreditation status to gain access to:
- Star Therapeutics Current Valuation
- Star Therapeutics Stock Price
- Star Therapeutics Management
- Available deals in Star Therapeutics and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Star Therapeutics Cap Table and Funding History by Share Class and Liquidity Preferences
- Star Therapeutics Revenue and Financials
- Star Therapeutics Highlights
- Star Therapeutics Business Model
- Star Therapeutics Risk Factors
- Star Therapeutics Research Report from SACRA Research
Trading Star Therapeutics Stock
How to invest in Star Therapeutics stock?
Accredited investors can buy pre-IPO stock in companies like Star Therapeutics through EquityZen funds. These investments are made available by existing Star Therapeutics shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Star Therapeutics stock?
Shareholders can sell their Star Therapeutics stock through EquityZen's private company marketplace. EquityZen's network includes over 360K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 46K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
